Combining Three Peripheral Blood Biomarkers to Stratify Rheumatoid Arthritis–Associated Interstitial Lung Disease Risk

Documenti analoghi

• Performance of an Idiopathic Pulmonary Fibrosis–Derived Multibiomarker Panel for Rheumatoid Arthritis–Associated Interstitial Lung Disease
  di: Brent A. Luedders, et al.
  Pubblicazione: (2026)
• Peripheral Biomarker Signatures in Rheumatoid Arthritis–Associated Interstitial Lung Disease
  di: Austin M. Wheeler, et al.
  Pubblicazione: (2025)
• Antibodies to Malondialdehyde‐Acetaldehyde Adduct Are Associated With Prevalent and Incident Rheumatoid Arthritis–Associated Interstitial Lung Disease in US Veterans
  di: Nozima Aripova, et al.
  Pubblicazione: (2024)
• Performance of the Predicting Risk of Cardiovascular Disease Events Calculator in Rheumatoid Arthritis
  di: Tate M. Johnson, et al.
  Pubblicazione: (2026)
• The Risk of Lung Cancer in Rheumatoid Arthritis and Rheumatoid Arthritis–Associated Interstitial Lung Disease
  di: Rebecca T. Brooks, et al.
  Pubblicazione: (2024)